SYNACT SynAct Pharma AB (publ)

1.282USD13.00 SEK · STO-0.91%Mkt Cap: 71.79M USDP/E: —

SynAct Pharma AB (publ), a clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden. The company develops AP1189, a drug candidate in Phase 2 clinical t…